Revisiting liver metabolism through acetyl-CoA carboxylase inhibition

被引：1

作者：

Perez-Diaz, Armando Jesus ^{[1
]}

Nunez-Sanchez, Maria Angeles ^{[2
]}

Ramos-Molina, Bruno ^{[2
]}

机构：

[1] Univ ROMA TRE, Dept Sci, I-00146 Rome, Italy

[2] Biomed Res Inst Murcia IMIB, Obes Diabet & Metab Lab, Murcia 30120, Spain

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2024年 / 35卷 / 07期

关键词：

NASH;

D O I：

10.1016/j.tem.2024.04.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Liver-targeted acetyl-coenzyme A (CoA) carboxylase (ACC) inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD) trials reveal notable secondary effects: hypertriglyceridemia and altered glucose metabolism, paradoxically with reduced hepatic steatosis. In their study, Deja et al. explored how hepatic ACC influences metabolism using different pharmacological and genetic methods, coupled with targeted metabolomics and stable isotope-based tracing techniques.

引用

页码：563 / 565

页数：3

共 50 条

[21] WHEAT ACETYL-COA CARBOXYLASE
GORNICKI, P
HASELKORN, R
PLANT MOLECULAR BIOLOGY, 1993, 22 (03) : 547 - 552
[22] REGULATION OF ACETYL-COA CARBOXYLASE
KIM, KH
CURRENT TOPICS IN CELLULAR REGULATION, 1983, 22 : 143 - 176
[23] REGULATION OF ACETYL-COA CARBOXYLASE
不详
NUTRITION REVIEWS, 1979, 37 (03) : 92 - 93
[24] Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Huard, Kim
Smith, Aaron C.
Cappon, Gregg
Dow, Robert L.
Edmonds, David J.
El-Kattan, Ayman
Esler, William P.
Fernando, Dilinie P.
Griffith, David A.
Kalgutkar, Amit S.
Ross, Trenton T.
Bagley, Scott W.
Beebe, David
Bi, Yi-An
Cabral, Shawn
Crowley, Collin
Doran, Shawn D.
Dowling, Matthew S.
Liras, Spiros
Mascitti, Vincent
Niosi, Mark
Pfefferkorn, Jeffrey A.
Polivkova, Jana
Preville, Cathy
Price, David A.
Shavnya, Andre
Shirai, Norimitsu
Smith, Andrew H.
Southers, James R.
Tess, David A.
Thuma, Benjamin A.
Varma, Manthena V.
Yang, Xiaojing
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 10879 - 10896
[25] Liver Selective Acetyl-CoA Carboxylase Inhibition Inhibits Hepatocellular Carcinoma in a Cirrhosis Model
DePeralta, Danielle K.
Wei, Lan
Harriman, Geraldine
Greenwood, Jeremy
Westlin, William F.
Harwood, James
Bhat, Sathesh
Kapeller, Rosana
Fuchs, Bryan C.
Tanabe, Kenneth K.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (03) : S23 - S24
[26] Therapeutic Utility of Liver-Specific Acetyl-CoA Carboxylase Inhibition for the Treatment of NAFLD
Goedeke, Leigh
Ellis, Matthew W.
Perry, Rachel J.
Vatner, Daniel F.
Wang, Ting
Bates, Jamie
Subramanian, Mani
Ray, Adrian S.
Shulman, Gerald I.
DIABETES, 2017, 66 : LB41 - LB41
[27] Structure, function and selective inhibition of bacterial acetyl-coa carboxylase
Polyak, S. W.
Abell, A. D.
Wilce, M. C. J.
Zhang, L.
Booker, G. W.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2012, 93 (03) : 983 - 992
[28] INHIBITION OF CORN ACETYL-COA CARBOXYLASE BY CYCLOHEXANEDIONE AND ARYLOXYPHENOXYPROPIONATE HERBICIDES
BURTON, JD
GRONWALD, JW
SOMERS, DA
GENGENBACH, BG
WYSE, DL
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1989, 34 (01) : 76 - 85
[29] Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD
Imai, Norihiro
Cohen, David E.
HEPATOLOGY, 2018, 68 (06) : 2062 - 2065
[30] ACETYL-COA CARBOXYLASE ACTIVITY AS A PARAMETER OF LIPID-METABOLISM
STURM, G
SIEBERT, G
ERNAHRUNGS-UMSCHAU, 1979, 26 (01): : 9 - 9

← 1 2 3 4 5 →